Post de TreeFrog Therapeutics

Exciting news! We are thrilled to announce a major partnership for us at TreeFrog Therapeutics! We have signed an exclusive licensing and collaboration agreement with Vertex Pharmaceuticals in type 1 diabetes. The deal provides Vertex with an exclusive license to our GMP compliant cell therapy technology, C-Stem, which aims to scale up investigational fully differentiated pancreatic islet cells.   Read full press release here: https://lnkd.in/ehANN8_K   #TreeFrogTherapeutics #VertexPharmaceuticals #T1D #CellTherapy #Partnership

🌟 Exciting Announcement for all young researchers in Japan! 🌟   We are delighted to announce the start of applications for The TreeFrog Young Investigators Travel Grant, in collaboration with The Japanese Society for Regenerative Medicine (JSRM)! 🧬   The TreeFrog Travel Grant supports young researchers by providing international exposure and fostering exchanges beyond Japan's scientific and clinical communities. This is a fantastic opportunity to gain experience, network globally, and present groundbreaking research. 🌐🔬   Check out the details and apply now!    📅 Application Deadline : 30/9/2024 https://lnkd.in/d5FcgYvK #JSRM #TravelGrant #YoungResearchers #ISCT #ISSCR #TERMIS #ApplyNow #CellTherapyForAll   ---in Japanese---   🌟 TreeFrog Therapeuticsからのお知らせ🌟   本年度も日本再生医療学会と共催のThe TreeFrog Young Investigators Travel Grant（国際学会渡航費助成）の募集が開始となりました。🧬 このトラベルグラントは日本の若手研究者に国際的な活躍の場を提供し、グローバルな交流やネットワーク構築促進の支援を目的としています。 皆さまのご応募をお待ちしております！   📅 応募締切: 2024年9月30日 🔗https://lnkd.in/d7CpBTrq   #JSRM #トラベルグラント #再生医療 #ISCT #ISSCR #TERMIS #CellTherapyForAll

Basile Gurchenkov is bringing our product into light, a key step to create safe and efficient cell therapy for all! A quick throw back to this post as the summer was for a significant part of us dedicated to another, more recreative, use of light. Very proud of our dedication to imaging as a tool to push forward cell and tissue therapies!

Want to see more Froggies in Austin, Texas next March 2025? Help us highlight the challenges & promise of cell therapy by voting for us to present at #SXSW 2025! We know the potential of cell therapy is huge! But there are still obstacles and one of the MAJOR challenges is to produce enough quality cells at scale, efficiently as patients require millions or even billions of cells for treatment, depending on the disease. At TreeFrog Therapeutics, our extremely talented team have invented a technology to overcome this challenge with a mission to achieve our purpose of Cell therapy for All. Click to join the community & vote! #SXSW 2025 #CellTherapyForAll #Innovation https://lnkd.in/enwA8stx

We are delighted to announce a new Froggy 🐸 joining the Executive Committee! Welcome to Peter Andersen, our new Chief Research & Development Officer. Check out the appointment below! https://lnkd.in/ecFUB3s5

CEO Frédéric Desdouits finished up the week nicely with a visit to our partners Vertex Pharmaceuticals Paris office, to spend some time exchanging with their France General Manager, Nicolas Renard. Bon weekend à tous! #globalcollaboration #celltherapy #innovation

🐸 Alert!! Froggies can be seeing roaming everywhere in Hamburg today at the International Society for Stem Cell Research meeting! if you have not reached out to learn more about TreeFrog Therapeutics, keep an eye out for them! Kévin Alessandri, Maxime Feyeux, Jens Schröder, MD PhD, Caroline Royer (PhD), Anne Mouré, Myriam Abarkan, Lucie Remichius, Clément Rieu, Joffrey MIANNE Bonus points if you find Clément Rieu and wish him Happy Birthday! #ISSCR2024 #CellTherapyForAll #Innovation #Biotech

[PRESS RELEASE] TreeFrog Therapeutics participates in an innovation showcase and poster session at the International Society for Stem Cell Research (ISSCR) annual meeting Tomorrow kicks off the annual meeting in #Hamburg, Germany and the team Maxime Feyeux, Joffrey MIANNE and Clément Rieu are ready to wow the attendees during an innovation showcase to deep dive on our transformational technology, C-Stem™ , a platform that was developed with the best talent in stem cell biology, biophysics and bioengineering. We will also be presenting the latest data on our lead program in Parkinson’s disease. If you want to more about the science and technology, Kévin Alessandri, Jens Schröder, MD PhD and Caroline Royer will also be on the ground and ready for discussions! Read the full press release on our website: https://lnkd.in/eGXipTjC #ISSCR2024 #CellTherapyForAll #iPSC #Biophysics #Biotech

If you are attending the 30th annual meeting of the Japan Society of Gene and Cell Therapy next week in the beautiful Yokohama city and want to know more about TreeFrog Therapeutics and our unique approach to cell therapy development, reach out to Francois Renault-Mihara, our lead scientist in Japan who will be onsite and is open for meetings!